Solution Structure of the RNase H Domain of the HIV-1 Reverse Transcriptase in the Presence of Magnesium
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
This paper presents the first solution structure of the RNase H domain of HIV-1 reverse transcriptase (RT) determined by NMR methods. The solution conditions in this study were at physiological pH in the presence of Mg(2+). An investigation of the dependence of the (1)H-(15)N HSQC spectrum of the RNase H domain on [Mg(2+)] indicates that Mg(2+) produces significant, global effects on the amide chemical shifts, implying that divalent metal ion binding is important for stabilizing the structure of the isolated domain in solution. Analysis of amide shift data as a function of MgCl(2) concentration using either a single- or two-site binding model indicated that the latter provided a significantly improved fit, with the K(D) for site A = 2.7-3.2 mM and K(D) for site B approximately 35 mM, calculated on the assumption that site A is already occupied. Resonances of the [U-(13)C,(15)N]RNase H domain, measured at pH 6.8, in 80 mM MgCl(2), were assigned and NOESY data collected in order to determine the structure. Assignment of the NOESY spectra using the ARIA program resulted in a high-resolution structure for residues 6-114 which was similar to the crystal structure of the isolated domain,. The data were insufficient to define a compact structure for the C-terminal residues after 114. Residues I134-L138 located at the C-terminus are highly disordered and give rise to relatively sharp and intense amide resonances, while the amide resonances for the segment from E124 to A132 appear to be largely absent and are presumably subject to significant exchange broadening between different conformational states. Comparisons with crystal structure data for the full reverse transcriptase molecule indicate that the corresponding region is absent in nearly all of the crystal structures determined for the P2(1)2(1)2(1) space group, while these residues adopt an alpha-helix in structures determined for other symmetry groups. This structural heterogeneity indicates that significant conformational variability exists for this segment of the full reverse transcriptase enzyme as well, and the structure of the C-terminal peptide can be selected or deselected, depending on crystallization conditions. This analysis, along with the structural characterization contained herein, challenges the previous paradigm that the dynamic behavior of the isolated RNase H domain differs substantially from the behavior in the intact enzyme. The poor Mg(2+) binding and conformational flexibility of residues located near the active site indicate that substrate binding is a precondition for metal ion binding and for selecting the active site conformation of the RNase H domain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein backbone angle restraints from searching a database for chemical shift and sequence homology
Cornilescu, G., Delaglio, F., & Bax, A. (1999) · Journal of Biomolecular NMR · doi:10.1023/a:1008392405740 · Cited by 2,957
Cowan, J. A., Ohyama, T., Howard, K., Rausch, J. W., Cowan, S. M. L., & Le Grice, S. F. J. (2000) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750050009 · Cited by 51
Research works printed but not linked: 51
- Schatz O., 1989, FEBS Lett., 257, 10.1016/0014-5793(89)81559-5 · DOI · Paper page
- Schatz O., 1990, EMBO J., 9, 10.1002/j.1460-2075.1990.tb08224.x · DOI
- Tisdale M. S., T., 1991, J. Gen. Virol., 72, 66
- Becerra S. P., 1990, FEBS Lett., 270, 80, 10.1016/0014-5793(90)81238-J · DOI · Paper page
- Hostomsky Z. H., Z., 1991, Proc. Natl. Acad. Sci. U.S.A. 88, 1148−1152
- Stammers D. K., 1991, FEBS Lett., 283, 10.1016/0014-5793(91)80613-8 · DOI · Paper page
- Evans D. B., 1991, J. Biol. Chem., 266
- Huang H., 1998, Science 282, 1669−1675
- Ren J., 1995, Structure 3, 915−926
- Ren J., 1995, Nat. Struct. Biol. 2, 293−302
- Sarafianos S. G., 1999, R137−R146.
- Davies J. F., II, 1991, Science, 252, 95
- Chattopadhyay D., 1993, Acta Crystallogr., Sect. D, 49, 10.1107/S0907444993002409 · DOI
- Powers R., 1992, Biochemistry 31, 9150−9157
- Powers R., 1991, J. Mol. Biol., 221
- Kern G., 1998, Protein Sci. 7, 2164−2174
- Oda Y., 1991, J. Biomol. NMR, 1
- Nakamura H., 1991, Proc. Natl. Acad. Sci. U.S.A. 88, 11535−11539
- Beese L. S., 1991, EMBO J., 10, 33, 10.1002/j.1460-2075.1991.tb07917.x · DOI · Paper page
- Yang W., 1995, Structure 3, 131−134
- Cirino N. M., 1995, Biochemistry 34, 9936−9943
- Katayanagi K., 1993, Proteins 17, 337−346
- Goedken E. R., 2001, J. Biol. Chem., 276, 10.1074/jbc.M009626200 · DOI · Paper page
- Arts E. J., 1998, Prog. Nucleic Acid Res. Mol. Biol. 58, 339−393
- Delaglio F., 1995, J. Biomol. NMR, 6, 10.1007/BF00197809 · DOI · Paper page
- Johnson B. A., 1994, J. Biomol. NMR, 4, 10.1007/BF00404272 · DOI · Paper page
- Koradi R., 1996, J. Mol. Graphics, 14, 55, 10.1016/0263-7855(96)00009-4 · DOI · Paper page
- Muhandiram D. R., 1994, J. Magn. Reson., Ser. B, 103, 10.1006/jmrb.1994.1032 · DOI · Paper page
- Pascal S. M., 1994, J. Magn. Reson., Ser. B, 103, 10.1006/jmrb.1994.1031 · DOI · Paper page
- Grzesiek S., 1993, J. Magn. Reson., Ser. B, 101, 10.1006/jmrb.1993.1019 · DOI · Paper page
- Logan T. M., 1993, J. Biomol. NMR, 3, 10.1007/BF00178264 · DOI · Paper page
- Yamazaki T., 1993, J. Am. Chem. Soc., 115, 10.1021/ja00076a099 · DOI · Paper page
- Kay L. E., 1994, J. Magn. Reson., Ser. A, 109
- Vuister G. W., 1993, J. Magn. Reson., Ser. B, 101, 10.1006/jmrb.1993.1035 · DOI · Paper page
- Wishart D. S., 1994, J. Biomol. NMR, 4, 10.1007/BF00175245 · DOI · Paper page
- Wishart D. S., 1992, Biochemistry 31, 1647−1651
- Nilges M., 1995, J. Mol. Biol., 245, 10.1006/jmbi.1994.0053 · DOI · Paper page
- Nilges M., 1997, S53−S57.
- Nilges M., 1998, Prog. NMR Spectrosc. 32, 107−139
- Linge J. P., 1999, J. Biomol. NMR, 13, 59, 10.1023/A:1008365802830 · DOI · Paper page
- Brunger A. T., 1998, Acta Crystallogr., Sect. D, 54, 10.1107/S0907444998003254 · DOI · Paper page
- Cristofaro J. V., 2002, Biochemistry 41, 10968−10975
- Levy L. A., 1988, Biochemistry 27, 4041−4048
- Heinonen E., 1987, Biochim. Biophys. Acta, 898
- Grubbs R. D., 1987, Magnesium 6, 113−127
- Takimoto K., 1985, J. Biochem. (Tokyo), 98, 10.1093/oxfordjournals.jbchem.a135290 · DOI
- Leech A. P., 1993, Eur. J. Biochem., 212, 10.1111/j.1432-1033.1993.tb17707.x · DOI
- Wilkie J., 1995, J. Chem. Soc., Perkin Trans., 1
- Nigou, J., Dover, L. G., and Besra, G. S. (2002)Biochemistry41, 4392−4398. · doi:10.1021/bi0160056
- Laskowski R. A., 1998, Curr. Opin. Struct. Biol. 8, 631−639
- Abbreviations, human immunodeficiency virus type 1
Cited by
Sarafianos, S. G., Marchand, B., Das, K., Himmel, D. M., Parniak, M. A., Hughes, S. H., & Arnold, E. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.071 · Cited by 535
RNase H activity: structure, specificity, and function in reverse transcription
Schultz, S. J., & Champoux, J. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.12.007 · Cited by 150
Avoiding drug resistance in HIV reverse transcriptase
Cilento, M. E., Kirby, K. A., & Sarafianos, S. G. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00967 · Cited by 106
Recent progress in the research of small molecule HIV-1 RNase H inhibitors
Cao, L., Song, W., Clercq, E., Zhan, P., & Liu, X. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140120121158 · Cited by 34
Retroviral RNase H: structure, mechanism, and inhibition
(2021) · The Enzymes · doi:10.1016/bs.enz.2021.07.007 · Cited by 13
Metadata
- Authors
- Pari, K., Mueller, G. A., DeRose, E. F., Kirby, T. W., & London, R. E.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2003-01-01
- Volume
- 42
- Issue
- 3
- Pages
- 639-650
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2024736649
- Cited by
- 53
- References
- 2
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.